Imran Khalifa

Imran Khalifa is an experienced professional in clinical manufacturing and biotechnology, currently serving as Supervisor of Individualized Neoantigen Therapy (INT/DNA) Clinical Manufacturing at Moderna since March 2023. Prior to this role, Imran held the position of Manager of Preclinical Production eRNA (circRNA) at Laronde from October 2021 to February 2023, and served as Senior Lead Clinical Manufacturing Cell Therapy at Minovia Therapeutics from February 2020 to October 2021. Additional experience includes Lead Commercial Manufacturing at Ocular Therapeutix, Inc., Chemistry Associate II in Cyclotron Operations at Lantheus Medical Imaging, and Sr. Associate in mRNA Preclinical Operation at Moderna Therapeutics. Imran began a career in production at Shire as a Production Associate II and Production Associate between September 2012 and February 2016. Imran holds an Associate of Science degree in Biotechnology from Middlesex Community College, completed in 2012, and graduated from Woburn Memorial High School in 2008.